Hedera Dx
PrivateLast Round
Series A
May 27, 2025
Total Funding Raised
$30.9M
Momentum Score
50 /100
Company Overview
Hedera Dx is a Swiss biotechnology company founded in 2021 that specializes in precision oncology. The company develops and provides liquid biopsy solutions to hospital laboratories, enabling them to conduct in-house, blood-based cancer testing. Its integrated platform combines advanced molecular diagnostics with a software solution, Hedera Prime, to analyze circulating tumor DNA (ctDNA), identify biomarkers, and guide personalized treatment decisions for cancer patients. Hedera Dx aims to make these advanced diagnostic tools more accessible and cost-effective, particularly for healthcare systems outside the United States. The company's mission is to remove structural barriers in oncology and improve patient access to targeted therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Healthcare Analytics, Drug Discovery
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS, Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hedera Dx Comps
Public and private peers based on sector, stage, and business model.
Hedera Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2025 | ||||
| Seed | Sep 21, 2022 |
Key People
Founding team and executive leadership
Hedera Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Top Harvest Capital | Series A |
| Tesi | Series A |
| Air Street Capital | Seed |
| Top Harvest Capital | Seed |
| Eyrir Venture Management | Series A |
| Amino Collective | Seed |
| Inventure | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2025
$17M round completed.
Hedera Dx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hedera Dx's valuation, stock price, and market status.
